Our study demonstrates that CAPE can function as a novel HAT inhibitor to prevent skin aging by downregulating UV-mediated acetylation of histone and non-histone proteins in both human skin cells and human skin tissues. The gene discussed is TMPRSS11D; the disease is skin aging.